mAb158-based PET radioligands (Uppsala University/BioArtic)

N/A

Report date: 2025/01/26 15:51:32

Base Information

Drug NamemAb158-based PET radioligands (Uppsala University/BioArtic)
Drug Alias NamemAb158-based PET radioligands (Uppsala University)mAb158-8D3 fusion protein (Uppsala University)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyRadiation-emitting productsBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionNeuroprotectantsPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUppsala University
China Registration ClassN/A

Develop Information

Active CompaniesBioarctic AbUppsala University
Inactive CompaniesN/A
Active IndicationsAlzheimer Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A